Hodgkin lymphoma transformation of chronic lymphocytic leukemia: Cases report and discussion

Medical Oncology

Volumn 31, Issue 1, 2014, Pages

  Kaåmierczak, Maciej ^a   Kroll Balcerzak, Renata ^a   Balcerzak, Andrzej ^a   Czechowska, Elzbieta ^b   Gil, Lidia ^a   Sawiński, Krzysztof ^a   Szczepaniak, Andrzej ^a   Komarnicki, Mieczysław ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Stanislaw Staszic Specialist Hospital   (Poland)

Author keywords

Chronic lymphocytic leukemia; Histological transformation; Hodgkin lymphoma; Trephine biopsy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER STAGING; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LEUKOCYTOSIS; LYMPHADENOPATHY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; ONCOGENESIS AND MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REED STERNBERG CELL; SPLENOMEGALY; BIOPSY; CELL TRANSFORMATION; COMPLICATION; DISEASE COURSE; FATALITY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PATHOLOGY;

ADULT; ANTINEOPLASTIC AGENTS; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED;

MLCS; MLOWN;

EID: 84890290490     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0800-8     Document Type: Article

References (19)

1. Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet. 2008;371:1017-29. (Pubitemid 351389535)
2. Cheson BD. The chronic lymphocytic leukemias. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practices of oncology. Philadelphia, PA: JB Lippincott; 2001. p. 2447-65.
3. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992;84:1422-7.
4. Tsimberidou AM, O'Brien S, Kantarjian HM, Koller C, Hagemeister FB, Fayad L, Lerner S, Bueso-Ramos CE, Keating MJ. Hodgkin transformation of chronic lymphocytic leukemia. The M. D. Anderson Cancer Center experience. Cancer. 2006;107:1294-302. (Pubitemid 44452779)
5. Adiga GU, Abebe L, Wiernik PH. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review. Am J Hematol. 2003;72:267-73. (Pubitemid 36383979)
6. Shin SS, Ben-Ezra J, Burke JS, Sheibani K, Rappaport H. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage. Am J Clin Pathol. 1993;99:658-62. (Pubitemid 23181810)
7. Fayad L, Robertson LE, O'Brien S, Manning JT, Wright S, Hagemeister F, Cabanillas F, Keating MJ. Hodgkin's disease variant of Richter's syndrome: experience at a single institution. Leuk Lymphoma. 1996;23:333-7. (Pubitemid 27029346)
8. Colak D, Ozyilkan O, Akcali Z, Bilezikci B. Hodgkin's disease in an elderly patent with B-cell chronic lymphocytic leukemia. Indian J Cancer. 2005;42:158-60. (Pubitemid 43511022)
9. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004;350(13):1328-37. (Pubitemid 38375368)
10. Ghosh SK, Perrine SP, Faller DV. Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies. Adv Virol. 2012;2012:509296.
11. Dolcetti R, Masucci MG. Epstein-Barr virus: induction and control of cell transformation. J Cell Physiol. 2003;196:207-18. (Pubitemid 36775867)
12. Ansell SM, Li CY, Lloyd RV, Phyliky RL. Epstein-Barr virus infection in Richter's transformation. Am J Hematol. 1999;60:99-104. (Pubitemid 29047428)
13. Bockorny B, Codreanu I, Dasanu CA. Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. Br J Haematol. 2011;156:50-66.
14. Hummel M, Anagnostopoulos I, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol. 1992;82:689-94. (Pubitemid 23011974)
15. Acaba L, Hallman D, Rodriguez-Morales E, Velez R, Velez-Garcia E. Simultaneous occurrence of Hodgkin's disease and chronic lymphocyte leukemia: a unique presentation. Bol Asoc Med P R. 2000;92:12-4.
16. Dolcetti R, Carbone A. Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? Infect Agent Cancer. 2010;5:22-6.
17. Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Bouland F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horowitz S, Faller DV. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 2007;109(6):2571-8. (Pubitemid 46425904)
18. Ghosh SK, Perrine SP, Williams RM, Faller DV. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 2012;119(4):1008-17.
19. Furtado M, Rule S. Emerging pharmacotherapy for relapsed or refractory Hodgkin's lymphoma: focus on brentuximab vedotin. Clin Med Insights Oncol. 2012;6:31-9.